|Articles|October 1, 2003

October 2003
Volume 9
Issue 10

Impact of Maine's Medicaid Drug Formulary Change on Non-Medicaid Markets: Spillover Effects of a Restrictive Drug Formulary

Author(s)Y. Richard Wang, MD, PhD, Mark V. Pauly, PhD, Y. Aileen Lin, MS

Download PDF: Impact of Maine's Medicaid Drug Formulary Change on Non-Medicaid Markets: Spillover Effects of a Restrictive Drug Formulary

Articles in this issue

almost 23 years ago

Article

The Ripple Effects of a Restrictive Medicaid Formulary

almost 23 years ago

Article

Smoking Status Identification: Two Managed Care Organizations' Experiences With a Pilot Project to Implement Identification Systems in Independent Practice Associations

almost 23 years ago

Article

A Clinical Decision and Economic Analysis Model of Cancer Pain Management

almost 23 years ago

Article

Barriers to Mental Health Referral From Pediatric Primary Care Settings

almost 23 years ago

Article

Better Bone Density Reporting: T-score Report Versus Fracture Risk Report With Outcome Analysis

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Impact of Maine's Medicaid Drug Formulary Change on Non-Medicaid Markets: Spillover Effects of a Restrictive Drug Formulary

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Trump Childhood Vaccine Order: What It Means for Parents and Payers

Senate Unveils Sweeping Bill to Reform 340B Drug Program

Occupational Triggers Fuel Half of CHE Cases, Spanish Study Finds

Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation

Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD